GUILLON, Jean; VINCENZI, Marian; PINAUD, Noël; RONGA, Luisa; ROSSI, Filomena; SAVRIMOUTOU, Solène; MOREAU, Stéphane; DESPLAT, Vanessa; MARCHIVIE, Mathieu

doi:10.21767/2470-9905.100018

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

GUILLON, Jean
Régulations Naturelles et Artificielles [ARNA]

VINCENZI, Marian
Régulations Naturelles et Artificielles [ARNA]
Department of Pharmacy and CIRPeB

PINAUD, Noël
Institut des Sciences Moléculaires [ISM]

Langue

Article de revue

Ce document a été publié dans

Structural Chemistry & Crystallography Communication. 2016, vol. 2, n° 1, p. 18

Insight Medical Publishing

Résumé en anglais

The X-ray crystal structure of 3-{4-[(4-(2-oxo-2,3-dihydro-1H-benzimidazol- 1-yl)piperidin-1-yl)benzyl]}-2-phenylindole, a compound that showed high cytotoxic potential against various leukemia cell lines, was established. The 3D spatial determination confirmed the structure in the solid state. It crystallizes in the triclinic space group P-1 with cell parameters a=9.572(7) Å, b=11.091(2) Å, c=15.976(4) Å, α=92.53(2), β=105.45(3), γ=94.65(3), V=1625.6(13) Å3 and Z=2. The crystal structure was refined to final values of R1=0.0638 and wR2=0.1800. The crystal packing is controlled by intermolecular hydrogen bonding and C-H π interactions. In addition, these new data could be further used to clarify the mechanism of action, implicating the antiproliferative effect of this new synthetic indole derivative on human leukemic cells.< Réduire

Mots clés en anglais

Antiproliferative activity

R factor

Single-crystal x-ray study

Indole derivative

Métadonnées

Licence d’utilisation du document

Synthesis and crystal structure of 3-{4-[(4-(2-Oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)benzyl]}-2-phenylindole

Langue

Ce document a été publié dans

Résumé en anglais

Mots clés en anglais

DOI

Origine

Unités de recherche